BioLife Solutions, Inc. ( BLFS) - Key Metrics
BLFS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.58 | $0.92 | $0.13 | $0.13 |
| 2026Q1 | $0.57 | $0.02 | -$0.01 | -$0.01 |
| 2025Q4 | $0.39 | $0.07 | $0.10 | -$0.20 |
| 2025Q3 | $0.59 | $0.01 | $0.13 | $0.06 |
| 2025Q2 | $0.53 | -$0.33 | $0.15 | $0.12 |
BLFS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 7.67 |
| 2026Q1 | 0% | 194.69 |
| 2025Q4 | 0% | 79.02 |
| 2025Q3 | 0% | 490.58 |
| 2025Q2 | 0% | -16.32 |
BLFS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.47% | 0% |
| 2026Q1 | -0.07% | 0% |
| 2025Q4 | -0.83% | 0% |
| 2025Q3 | 0.23% | 0% |
| 2025Q2 | 0.55% | 0% |
BLFS
Price: $38.61
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.00 USD
P/E Ratio: 34.82
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 447300
Ebitda: -233997Market Capitalization: 1.8 billion